<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Additionally, synergy was also noted for another two interactions, namely GR-EO in combination with Chloramphenicol against 
 <italic class="italic">B. subtilis</italic> (FICI of 0.38), and with Streptomycin against 
 <italic class="italic">S. aureus</italic> (FICI of 0.38). 
 <italic class="italic">Staphylococcus aureus</italic> is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections [
 <xref rid="B34-molecules-22-01561" ref-type="bibr" class="xref">34</xref>]. Therefore, treatment options of 
 <italic class="italic">S. aureus</italic> infections could include combined use of GR-EO and Streptomycin.
</p>
